Unmet therapeutic goals and potential treatable traits in a population of patients with severe uncontrolled asthma in Spain. ENEAS study
- 1 May 2019
- journal article
- research article
- Published by Elsevier in Respiratory Medicine
- Vol. 151, 49-54
Abstract
No abstract availableKeywords
Funding Information
- AstraZeneca
This publication has 25 references indexed in Scilit:
- Clinical Burden and Predictors of Asthma Exacerbations in Patients on Guideline-based Steps 4-6 Asthma Therapy in the TENOR CohortThe Journal of Allergy and Clinical Immunology: In Practice, 2014
- International ERS/ATS guidelines on definition, evaluation and treatment of severe asthmaEuropean Respiratory Journal, 2013
- Identification of Asthma Phenotypes Using Cluster Analysis in the Severe Asthma Research ProgramAmerican Journal of Respiratory and Critical Care Medicine, 2010
- The Prevalence of Nonadherence in Difficult AsthmaAmerican Journal of Respiratory and Critical Care Medicine, 2009
- Economic Cost of Treating the Patient With Asthma in Spain: The AsmaCost StudyArchivos de Bronconeumología, 2009
- An Official American Thoracic Society/European Respiratory Society Statement: Asthma Control and ExacerbationsAmerican Journal of Respiratory and Critical Care Medicine, 2009
- High serum levels of tumour necrosis factor‐α and interleukin‐8 in severe asthma: markers of systemic inflammation?Clinical & Experimental Allergy, 2006
- ATS/ERS Recommendations for Standardized Procedures for the Online and Offline Measurement of Exhaled Lower Respiratory Nitric Oxide and Nasal Nitric Oxide, 2005American Journal of Respiratory and Critical Care Medicine, 2005
- A Single Measure of FEV 1 Is Associated With Risk of Asthma Attacks in Long-term Follow-upChest, 2004
- Neutrophilic Inflammation in Severe Persistent AsthmaAmerican Journal of Respiratory and Critical Care Medicine, 1999